Skip to main content
Top
Published in: BMC Infectious Diseases 1/2010

Open Access 01-12-2010 | Case report

Plasmodium falciparum malaria and Parvovirus B19; a case of acute co-infection

Authors: F Ingrassia, A Gadaleta, P Maggi, G Pastore

Published in: BMC Infectious Diseases | Issue 1/2010

Login to get access

Abstract

Background

Co-infection with Plasmodium falciparum malaria and Parvovirus B19 in adults is an extremely rare occurrence and, apparently, only one case has been previously reported. Herein we describe a case of acute co-infection with severe anemia and renal failure.

Case presentation

The patient was a 34-year-old African man presenting myalgia, fatigue, headache, anemia and hepatosplenomegaly. A thin peripheral smear showed Plasmodium falciparum trophozoites and the patient was treated with oral mefloquine. After an initial amelioration, fever, fatigue and myalgia reappeared, the anemia worsened and there was evidence of acute renal failure. No malarial parasites were found with a blood smear. A bone marrow aspiration showed marked erythroid hypoplasia. Parvovirus B19-specific IgM and IgG and viremia were positive. The patient was treated with steroids and blood cell transfusions. After ten days, anemia and renal failure progressively decreased. When last seen, the patient was asymptomatic and the blood values were within the normal range.

Conclusions

The diagnosis of Parvovirus B19 acute infection should be considered in any case of persistent severe anemia and/or renal failure, even in clinical conditions that are well-known causes of anemia and renal failure, such as malaria.
Literature
1.
go back to reference Scarlata F, Gianelli E, Miceli S, Galimberti L, Antinori S: Acute parvovirus B19 infection and anemia during Plasmodium falciparum malaria. Clin Infect Dis. 2002, 35 (11): 1449-51. 10.1086/344452.CrossRefPubMed Scarlata F, Gianelli E, Miceli S, Galimberti L, Antinori S: Acute parvovirus B19 infection and anemia during Plasmodium falciparum malaria. Clin Infect Dis. 2002, 35 (11): 1449-51. 10.1086/344452.CrossRefPubMed
2.
go back to reference Menendez C, Fleming AF, Alonso PL: Malaria-related anemia. Parasitol Today. 2000, 16: 469-76. 10.1016/S0169-4758(00)01774-9.CrossRefPubMed Menendez C, Fleming AF, Alonso PL: Malaria-related anemia. Parasitol Today. 2000, 16: 469-76. 10.1016/S0169-4758(00)01774-9.CrossRefPubMed
3.
go back to reference Wildig J, Michon P, Siba P, et al: Parvovirus B19 infection contributes to severe anemia in young children in Papua New Guinea. J Infect Dis. 2006, 15;194 (2): 146-53. 10.1086/505082.CrossRef Wildig J, Michon P, Siba P, et al: Parvovirus B19 infection contributes to severe anemia in young children in Papua New Guinea. J Infect Dis. 2006, 15;194 (2): 146-53. 10.1086/505082.CrossRef
4.
go back to reference Gupta R, Singh T: Parvovirus B19 co-infection with falciparum malaria: a cause of severe anemia. Haematologica. 2005, 90 (Suppl): ECR4- Gupta R, Singh T: Parvovirus B19 co-infection with falciparum malaria: a cause of severe anemia. Haematologica. 2005, 90 (Suppl): ECR4-
5.
go back to reference Urganci N, Arapoglu M, Kayaalp N: Plasmodium falciparum malaria with coexisting parvovirus B19 infection. Indian Pediatr. 2003, 40 (4): 369-70.PubMed Urganci N, Arapoglu M, Kayaalp N: Plasmodium falciparum malaria with coexisting parvovirus B19 infection. Indian Pediatr. 2003, 40 (4): 369-70.PubMed
6.
go back to reference Lortholary O, Eliasewicz M, Dupont B, Courouce AM: Parvovirus B19 infection during acute Plasmodium falciparum malaria. Eur J Hematol. 1992, 49: 219-CrossRef Lortholary O, Eliasewicz M, Dupont B, Courouce AM: Parvovirus B19 infection during acute Plasmodium falciparum malaria. Eur J Hematol. 1992, 49: 219-CrossRef
7.
go back to reference Jones PH, Pickett LC, Anderson MJ, Pasvol GI: Human parvovirus infection in children and severe anemia seen in an area endemic for malaria. J Trop Med Hyg. 1990, 93: 67-70.PubMed Jones PH, Pickett LC, Anderson MJ, Pasvol GI: Human parvovirus infection in children and severe anemia seen in an area endemic for malaria. J Trop Med Hyg. 1990, 93: 67-70.PubMed
8.
go back to reference Ramirez JA, Coccia PA, Ferrero HA, Livellara B, Christiansen S, Gallo G: Tubulointerstitial nephritis associated with parvovirus beta19 infection. Medicina (B Aires). 2005, 65 (4): 333-7. Ramirez JA, Coccia PA, Ferrero HA, Livellara B, Christiansen S, Gallo G: Tubulointerstitial nephritis associated with parvovirus beta19 infection. Medicina (B Aires). 2005, 65 (4): 333-7.
9.
go back to reference Onguru P, Dede F, Bodur H, et al: Glomerulonephritis associating parvovirus B19 infection. Ren Fail. 2006, 28 (1): 85-8. 10.1080/08860220500461302.CrossRefPubMed Onguru P, Dede F, Bodur H, et al: Glomerulonephritis associating parvovirus B19 infection. Ren Fail. 2006, 28 (1): 85-8. 10.1080/08860220500461302.CrossRefPubMed
10.
go back to reference Taylor G, Drachenberg C, Faris-Young S: Renal involvement of human parvovirus B19 in an immunocompetent host. Clin Infect Dis. 2001, 32: 167-9. 10.1086/317556.CrossRefPubMed Taylor G, Drachenberg C, Faris-Young S: Renal involvement of human parvovirus B19 in an immunocompetent host. Clin Infect Dis. 2001, 32: 167-9. 10.1086/317556.CrossRefPubMed
Metadata
Title
Plasmodium falciparum malaria and Parvovirus B19; a case of acute co-infection
Authors
F Ingrassia
A Gadaleta
P Maggi
G Pastore
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2010
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-10-87

Other articles of this Issue 1/2010

BMC Infectious Diseases 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.